|Articles|October 2, 2021
Using ML, AI and RWD to Infer HCP Specialties
Author(s)IPM.ai
Pharmaceutical sales operations teams often rely on outdated or inaccurate data when prioritizing HCP targets, limiting promotional effectiveness. By applying artificial intelligence and machine learning to real world data, pharmaceutical companies can more effectively target physicians hiding in plain sight and PCPs behaving like specialists.
Related Content
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
Novartis to Layoff 322 NJ Employees: Report
3
Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement
4
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
5